News

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...
The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...